Abstract
Aims: Succinic semialdehyde dehydrogenase (SSADH) deficiency is a neurometabolic disease in which the degradation of γ-aminobutyric acid (GABA) is impaired. The purpose of this study was to report two novel ALDH5A1 mutations responsible for SSADH deficiency in a Chinese family and the prenatal diagnosis of an at-risk fetus with DNA sequencing.
Results: Genetic analysis of ALDH5A1, in a child with SSADH deficiency, parents, and 10 weeks’ gestation at-risk fetus and 100 healthy unrelated volunteers, was performed. The coding sequence and the intron/exon junctions of ALDH5A1 were analyzed by bidirectional DNA sequencing. The proband was identified to have a compound heterozygous mutations with c.496T>C (p.W166R) and c.589G>A (p.V197M). Each of his parents carried a deleterious mutation. DNA sequencing of chorionic villus revealed the fetus was a carrier, but not affected, and this was confirmed after birth by genetic analysis of umbilical cord blood and urine organic acid analysis. A study in 2003 described 35 mutations of ALDH5A1 in 54 unrelated families, and the current study and systematic literature review identified nine additional novel mutations in eight unrelated families bringing the total number of unique mutations of ALDH5A1 resulting in SSADH deficiency to 44, and the 44 mutations occur from exon 1 to exon 10. No mutational hotspots or prevalent mutations were observed, and all mutations appeared vital for the function of SSADH.
Conclusions: Two novel ALDH5A1 mutations likely responsible for SSADH deficiency were identified, and DNA sequencing provided an accurate diagnosis for an at-risk fetus whose sibling had SSADH deficiency.
References
[1] Pearl PL, Dorsey AM, Barrios ES, Gibson KM. Succinic semialdehyde dehydrogenase deficiency. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2013. 2004 May 05 [updated 2013 Sep 19].Search in Google Scholar
[2] Pearl PL, Gibson KM, Acosta MT, Vezina LG, Theodore WH, Rogawski MA, et al. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology. 2003;60:1413–7.10.1212/01.WNL.0000059549.70717.80Search in Google Scholar
[3] Pearl PL, Novotny EJ, Acosta MT, Jakobs C, Gibson KM. Succinic semialdehyde dehydrogenase deficiency in children and adults. Ann Neurol. 2003;6(54 Suppl):S73–80.10.1002/ana.10629Search in Google Scholar
[4] Gibson KM, Aramaki S, Sweetman L, Nyhan WL, DeVivo DC, Hodson AK, et al. Stable isotope dilution analysis of 4-hydroxybutyric acid: an accurate method for quantification in physiological fluids and the prenatal diagnosis of 4-hydroxybutyric aciduria. Biomed Environ Mass Spectrom. 1990;19:89–93.10.1002/bms.1200190207Search in Google Scholar
[5] Kim KJ, Pearl PL, Jensen K, Snead OC, Malaspina P, Jakobs C, et al. Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance. Antioxid Redox Signal. 2011;15:691–718.10.1089/ars.2010.3470Search in Google Scholar
[6] Vogel KR, Pearl PL, Theodore WH, McCarter RC, Jakobs C, Gibson KM. Thirty years beyond discovery – clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism. J Inherit Metab Dis. 2013;36:401–10.10.1007/s10545-012-9499-5Search in Google Scholar
[7] Trettel F, Malaspina P, Jodice C, Novelletto A, Slaughter CA, Caudle DL, et al. Human succinic semialdehyde dehydrogenase. Molecular cloning and chromosome localization. Adv Exp Med Biol. 1997;414:253–60.10.1007/978-1-4615-5871-2_29Search in Google Scholar
[8] Chambliss KL, Hinson DD, Trettel F, Malaspina P, Novelletto A, Jakobs C, et al. Two exon-skipping mutations as the molecular basis of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria). Am J Hum Genet. 1998;63:399–408.10.1086/301964Search in Google Scholar
[9] Jakobs C, Bojasch M, Monch E, Rating D, Siemes H, Hanefeld F. Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities: the probability of a new inborn error of metabolism. Clin Chim Acta. 1981;111:169–78.10.1016/0009-8981(81)90184-4Search in Google Scholar
[10] Gibson KM, Christensen E, Jakobs C, Fowler B, Clark MA, Hammersen G, et al. The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients. Pediatrics. 1997;99:567–74.10.1542/peds.99.4.567Search in Google Scholar PubMed
[11] Akaboshi S, Hogema BM, Novelletto A, Malaspina P, Salomons GS, Maropoulos GD, et al. Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency. Hum Mutat. 2003;22:442–50.10.1002/humu.10288Search in Google Scholar PubMed
[12] Hogema BM, Akaboshi S, Taylor M, Salomons GS, Jakobs C, Schutgens RB, et al. Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency: increased accuracy employing DNA, enzyme, and metabolite analyses. Mol Genet Metab. 2001;72:218–22.10.1006/mgme.2000.3145Search in Google Scholar PubMed
[13] den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet. 2001;109:121–4.10.1007/s004390100505Search in Google Scholar PubMed
[14] Human Genome Variation Society. Nomenclature for the description of sequence variants. 2013. http://www.hgvs.org/mutnomen. Accessed March 11, 2013.Search in Google Scholar
[15] Püttmann L, Stehr H, Garshasbi M, Hu H, Kahrizi K, Lipkowitz B, et al. A novel ALDH5A1 mutation is associated with succinic semialdehyde dehydrogenase deficiency and severe intellectual disability in an Iranian family. Am J Med Genet A. 2013;161A:1915–22.10.1002/ajmg.a.36030Search in Google Scholar PubMed
[16] Kwok JS, Yuen CL, Law LK, Tang NL, Cherk SW, Yuen YP. A novel ALDH5A1 mutation in a patient with succinic semialdehyde dehydrogenase deficiency. Pathology. 2012;44:280–2.10.1097/PAT.0b013e32835140c2Search in Google Scholar PubMed
[17] Yamakawa Y, Nakazawa T, Ishida A, Saito N, Komatsu M, Matsubara T, et al. A boy with a severe phenotype of succinic semialdehyde dehydrogenase deficiency. Brain Dev. 2012;34:107–12.10.1016/j.braindev.2011.05.003Search in Google Scholar PubMed
[18] Knerr I, Gibson KM, Murdoch G, Salomons GS, Jakobs C, Combs S, et al. Neuropathology in succinic semialdehyde dehydrogenase deficiency. Pediatr Neurol. 2010;42:255–8.10.1016/j.pediatrneurol.2009.11.011Search in Google Scholar PubMed PubMed Central
[19] Jung R, Rauch A, Salomons GS, Verhoeven NM, Jakobs C, Michael Gibson K, et al. Clinical, cytogenetic and molecular characterization of a patient with combined succinic semialdehyde dehydrogenase deficiency and incomplete WAGR syndrome with obesity. Mol Genet Metab. 2006;88:256–60.10.1016/j.ymgme.2006.02.003Search in Google Scholar PubMed
[20] Blasi P, Palmerio F, Caldarola S, Rizzo C, Carrozzo R, Gibson KM, et al. Succinic semialdehyde dehydrogenase deficiency: clinical, biochemical and molecular characterization of a new patient with severe phenotype and a novel mutation. Clin Genet. 2006;69:294–6.10.1111/j.1399-0004.2006.00579.xSearch in Google Scholar PubMed
[21] Bekri S, Fossoud C, Plaza G, Guenne A, Salomons GS, Jakobs C, et al. The molecular basis of succinic semialdehyde dehydrogenase deficiency in one family. Mol Genet Metab. 2004;81:347–51.10.1016/j.ymgme.2004.01.012Search in Google Scholar PubMed
[22] Wolf NI, Haas D, Hoffmann GF, Jakobs C, Salomons GS, Wevers RA, et al. Sedation with 4-hydroxybutyric acid: a potential pitfall in the diagnosis of SSADH deficiency. J Inherit Metab Dis. 2004;27:291–3.10.1023/B:BOLI.0000028842.15981.6eSearch in Google Scholar
[23] Wong CG, Chan KF, Gibson KM, Snead OC. Gamma-hydroxybutyric acid: neurobiology and toxicology of a recreational drug. Toxicol Rev. 2004;23:3–20.10.2165/00139709-200423010-00002Search in Google Scholar PubMed
[24] Wamelink MM, Roos B, Jansen EE, Mulder MF, Gibson KM, Jakobs C. 4-Hydroxybutyric aciduria associated with catheter usage: a diagnostic pitfall in the identification of SSADH deficiency. Mol Genet Metab. 2011;102:216–7.10.1016/j.ymgme.2010.10.001Search in Google Scholar PubMed PubMed Central
[25] Gibson KM, Hoffmann GF, Hodson AK, Bottiglieri T, Jakobs C. 4-hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics. 1998;29:14–22.10.1055/s-2007-973527Search in Google Scholar PubMed
[26] De Rango F, Leone O, Dato S, Novelletto A, Bruni AC, Berardelli M, et al. Cognitive functioning and survival in the elderly: the SSADH C538T polymorphism. Ann Hum Genet. 2008;72:630–5.10.1111/j.1469-1809.2008.00450.xSearch in Google Scholar PubMed
[27] Gibson KM, Baumann C, Ogier H, Rossier E, Vollmer B, Jakobs C. Pre- and postnatal diagnosis of succinic semialdehyde dehydrogenase deficiency using enzyme and metabolite assays. J Inherit Metab Dis. 1994;17:732–7.10.1007/BF00712016Search in Google Scholar PubMed
The authors stated that there are no conflicts of interest regarding the publication of this article.
©2016 by De Gruyter
